eHealth Inc. buy FXX
Start price
08.02.21
/
50%
€48.35
Target price
08.02.22
-
Performance (%)
16.56%
End price
24.03.21
€56.35
Summary
This prediction ended on 24.03.21 with a price of €56.35. The BUY prediction by FXX finished with a performance of 16.56%. FXX has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| eHealth Inc. | 4.363% | 4.363% | -47.203% | -92.428% |
| iShares Core DAX® | 2.112% | -0.367% | 13.466% | 16.854% |
| iShares Nasdaq 100 | -2.197% | -3.794% | 38.426% | 42.934% |
| iShares Nikkei 225® | -1.555% | -7.320% | 18.451% | 2.941% |
| iShares S&P 500 | -0.472% | -2.078% | 27.488% | 41.955% |
According to FXX what are the pros and cons of eHealth Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
Good rating
High Investments for future growth
ROE higher than 10% per year
Normal challenges to pay loans and raise capital
Capable Management
Good culture
Leading role in innovation
Some uniques
Differentiated customer and product portfolio
Growths much faster than the competition
Sustainability is important
Stable Large shareholder and/or long term investor
Medium risks for its business
Cons
Low dividend yield expected
negative Cash Flow expected
Risky balance sheet
Comments by FXX for this prediction
In the thread eHealth Inc. diskutieren
Buy eHealth Inc.